Amlodipine camsylate/Losartan Potassium

樟脑磺酸氨氯地平/氯沙坦钾

Report date: 2023/04/21 09:55:18

Base Information

Drug NameAmlodipine camsylate/Losartan Potassium
Drug Alias Name氨氯地平+氯沙坦ARB/CCBAmlozaarCCB/ARBBicartial +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockers
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2009/01/01
Country/TerritoryCzechiaSouth Korea
CombinationsYes Losartan PotassiumAmlodipine Camsylate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09DB06
Related LinksN/A